Acute Effects of Furosemide on Hemodynamics and Pulmonary Congestion in Acute Decompensated Heart Failure.

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

February 9, 2024

Study Completion Date

February 9, 2024

Conditions
Acute Heart Failure
Interventions
DRUG

Furosemide Injection

Intravenous administration of 80 mg furosemide is followed by assessing blood pressure, peripheral oxygen saturation, pulmonary fluid content by ReDS\*, and ultrasound examination of heart and lungs, including assessment of filling pressures with doppler and strain analysis. These measurements are repeated at multiple time points until 6 hours have elapsed.

Trial Locations (1)

2650

Amager-Hvidovre Hospital, Copenhagen

All Listed Sponsors
lead

Johannes Grand

OTHER

NCT06024889 - Acute Effects of Furosemide on Hemodynamics and Pulmonary Congestion in Acute Decompensated Heart Failure. | Biotech Hunter | Biotech Hunter